Jump to
Administrator Info
Name: Admin
Phone: 612-624-9996
Fax: 612-625-4410
Email: [email protected]
Mail: Microbiology Research Building, 1st floor mail room, MMC 2821, 689 SE 23rd Ave, Minneapolis, MN 55455
Summary
Dr. Rajasingham is an Infectious Diseases physician and physician-scientist at the University of Minnesota. Her primary research interest is to maximize the public health impact of screening HIV-infected persons for opportunistic infections in order to decrease HIV/AIDS-related mortality. She is particularly interested in the evaluation of cost-effective diagnostics and treatment algorithms to care of persons with advanced HIV disease. Dr. Rajasingham is the co-PI of a phase II randomized clinical trial in Uganda evaluating the safety of high dose AmBisome to prevent cryptococcal meningitis in persons with advanced HIV disease, and PI for an R01 cluster-randomized trial evaluating point-of-care diagnostics in persons with advanced HIV disease, funded by NIAID.
MD, University of Minnesota
Rajasingham R, Smith RM, Park BJ, Jarvis JN, Govender NP, Chiller TM, Denning DW, Loyse A, Boulware DR. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis. 2017 Aug;17(8):873-881. doi: 10.1016/S1473-3099(17)30243-8. Epub 2017 May 5. PMID: 28483415; PMCID: PMC5818156.,
Rajasingham R, Bangdiwala AS, Nicol MR, Skipper CP, Pastick KA, Axelrod ML, Pullen MF, Nascene AA, Williams DA, Engen NW, Okafor EC, Rini BI, Mayer IA, McDonald EG, Lee TC, Li P, MacKenzie LJ, Balko JM, Dunlop SJ, Hullsiek KH, Boulware DR, Lofgren SM; COVID PREP team. Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial. Clin Infect Dis. 2021 Jun 1;72(11):e835-e843. doi: 10.1093/cid/ciaa1571. PMID: 33068425; PMCID: PMC7665393.,
Nalintya E, Meya DB, Lofgren S, Huppler Hullsiek K, Boulware DR, Rajasingham R. A Prospective Evaluation of a Multisite Cryptococcal Screening and Treatment Program in HIV Clinics in Uganda. J Acquir Immune Defic Syndr. 2018 Jun 1;78(2):231-238. doi: 10.1097/QAI.0000000000001669. PMID: 29509588; PMCID: PMC5953806.,
Rajasingham R, Meya DB, Greene GS, Jordan A, Nakawuka M, Chiller TM, Boulware DR, Larson BA. Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis. PLoS One. 2019 Jan 10;14(1):e0210105. doi: 10.1371/journal.pone.0210105. PMID: 30629619; PMCID: PMC6328136.,
Dr. Rajasingham is a physician-scientist trained in the clinical practice of infectious diseases. Her research interests span evaluation and cost-effectiveness of point-of-care diagnostics in persons with advanced HIV disease, cryptococcal screening and prevention, and management of cryptococcal meningitis.
Research Projects
Rising Star, Mpls/St. Paul Magazine, 2020
Young Physician Scientists Award, American Society for Clinical Investigation, 2020